Immunotherapy for the Treatment of Urothelial Cancer Guideline Overview – SITC CPG Webinar

When:  Aug 25, 2021 from 17:30 to 18:30 (ET)
18CIG-logo-rgb.jpgOn Wednesday, August 25, 2021 from 5:30 – 6:30 p.m. ET, join leading experts from the SITC Urothelial Cancer Immunotherapy Guideline Expert Panel for the "Immunotherapy for the Treatment of Urothelial Cancer Guideline Overview - SITC CPG Webinar." This FREE CME-, CNE-, CPE-certified webinar will include selected expert panel recommendations that are applicable to the most common clinical scenarios for a disease setting/modality. A dedicated question-and-answer session during the webinar will provide an opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.

Webinar Faculty:
  • Moderator: Ashish M. Kamat, MD, MBBS, FACS — The University of Texas MD Anderson Cancer Center (Expert Panel Chair)
  • Matthew D. Galsky, MD — Tisch Cancer Institute at Mount Sinai Medical Center (Expert Panel Chair)
  • Peter C. Black, MD — University of British Columbia (Expert Panel Member)
  • Arjun V. Balar, MD — Perlmutter Cancer Center, NYU Langone Medical Center (Expert Panel Member)

Learning Objectives:
  1. Select appropriate diagnostics and biomarker testing tailored to the clinical setting for a patient being considered for immunotherapy based on the expert panel recommendations in the CPG
  2. Implement immunotherapy treatments effectively and appropriately for urothelial cancer according to the recommendations in the SITC CPG
  3. Appraise patterns of response to immunotherapy in order to appropriately monitor and manage patients during treatment

Continuing Education Credit Information:
Continuing Education Credits are available for physicians, nurses, and pharmacists. To view full accreditation information, click here.

*Please note that by clicking the "register now" button you have the option to register for one or multiple webinars within this series.

This webinar is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.

This webinar is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, and Merck & Co., Inc. 

#BladderCancer #Webinar #ClinicalPracticeGuideline #CME #CNE #CPE #Clinician #2021